The retail collaboration platform developer has now raised more than $52m in total, existing backer SEB Alliance returning for a $23.9m round.

Based on research at University of Adelaide, Royal Adelaide Hospital and Johns Hopkins's Hospital, Glyscend is working on a pill to treat type 2 diabetes.

Francisco Partners has injected $30m into Kyruus, five months after the patient-matching platform developer received $42m in a series D round featuring Salesforce and Providence St Joseph.

Existing investor Septwolves returned as the IoT semiconductor maker secured about $28m that will fuel research and development.

The Sharia-compliant wealth management service raised the cash in a round co-led by Saudi Aramco Entrepreneurship Ventures.

The real estate services portal increased its overall funding to $37m with a round co-led by SoftBank Ventures Asia that also featured RSquare.

Rockwell Automation and existing investor ABB Technology Ventures contributed to a $17.8m round that hiked the digital circuit breaker developer's overall funding to $23m.

DocsApp, whose investors include DeNA and Techmatrix, has joined forces with MediBuddy in deal buoyed by a $20m round backed by Mitsui Sumitomo.

University of Chicago returned to contribute to a series B round for smart oven provider Tovala.

Sumitomo Corporation Europe and existing investor Tekfen Ventures helped provide $28.5m for the gene-edited crop developer's latest round.